Fact checked by Nick Blackmer Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, ...

Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US patients at a discount.

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

American pharmaceutical company Eli Lilly has started selling higher doses of its popular weight-loss drug Zepbound in vials, at a $150 discount to the cost of the injector pen versions.

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through ... to a list price of $1,086.37 per monthly injector pen. Wegovy’s maker, Novo Nordisk, is charging $499 per ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

They’re also more appealing to patients, especially those who have needle phobias ... higher doses of Zepbound in the U.S. at a discount of $150 compared to the injector pen versions, Reuters ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount ... a list price of $1,086.37 per monthly injector pen.